Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Seprify | Freiburg | Series A | $15.6M | 2026-03-10 |
| UniSieve | Zürich | Series A | $9.0M | 2026-10-08 |
| KEMARO AG | Eschlikon | Series B | $5.0M | 2026-04-23 |
| Cutiss | Zürich | Series C | $38.8M | 2025-09-10 |
| Rapidata | Zürich | Seed | $8.5M | 2026-02-19 |
| ORamaVR | Geneva | Seed | $4.5M | 2026-01-27 |
| Alentis Therapeutics | Allschwil | Series D | $181.4M | 2024-11-12 |
| Swisspod | Monthey | Seed | $13.0M | 2025-11-25 |
8 rows of the CSV in 5 of its 18 columns.
- The 29 Innosuisse portfolio companies have raised $343.7M in total.
- 6 of them closed their most recent round in the last 12 months, $55.6M combined.
- The largest of those rounds is Seprify's $15.6M Series A, dated March 2026.
- The most recent is UniSieve's $9.0M Series A on 8 October 2026.
- Venture Kick is an investor in 10 of them, more than any other fund.
- Health care is the most common sector, with 17 companies (59%).
- 28% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (62% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
19 of 29| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich, Switzerland | Series A | $9.0M | 2026-10-08 | $19.7M | Venture Kick, European Innovation Council, Innosuisse +1 | 11 to 50 | 2018 |
| KEMARO AG | KEMARO AG engineers autonomous robotics. | Artificial intelligence | Eschlikon, Switzerland | Series B | $5.0M | 2026-04-23 | $10.4M | Innosuisse, Spicehaus Partners | 11 to 50 | 2016 |
| Rapidata | Rapidata is a data processing platform that offers human-verified data labeling and processing services at scale. | Hardware | Zürich, Switzerland | Seed | $8.5M | 2026-02-19 | $11.5M | Venture Kick, Acequia Capital (AceCap), Innosuisse +2 | 11 to 50 | 2023 |
| ORamaVR | ORamaVR develops extended reality software that speeds up computational medical applications. | Education | Geneva, Switzerland | Seed | $4.5M | 2026-01-27 | $5.9M | European Commission, Innosuisse, FONGIT +1 | 11 to 50 | 2016 |
| Swisspod | Swisspod develops energy-efficient hyperloop systems for high-speed transportation. | Energy | Monthey, Switzerland | Seed | $13.0M | 2025-11-25 | $25.5M | European Innovation Council, Innosuisse, Seldor Capital +1 | 101 to 250 | 2019 |
| Veezoo | Veezoo is a software company offering natural-language analytics for cloud databases. | Artificial intelligence | Zürich, Switzerland | Series A | $6.0M | 2025-09-22 | $6.7M | Tenity, SICTIC, Innosuisse | 1 to 10 | 2016 |
| Cutiss | Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. | Biotech | Zürich, Switzerland | Series C | $38.8M | 2025-09-10 | $94.6M | Innosuisse | 11 to 50 | 2017 |
| Lyfegen | Lyfegen provides SaaS rebate management software for the healthcare industry. | Fintech | Basel, Switzerland | Series A | $5.7M | 2024-12-11 | MassChallenge, Innosuisse, APEX Ventures +1 | 51 to 100 | 2018 | |
| Alentis Therapeutics | Alentis Therapeutics develops novel therapeutics for advanced liver disease and cancer. | Biotech | Allschwil, Switzerland | Series D | $181.4M | 2024-11-12 | Bpifrance, HTGF (High-Tech Gruenderfonds), RA Capital Management +2 | 51 to 100 | 2019 | |
| ImmunOs Therapeutics | ImmunOs Therapeutics is a clinical-stage biotechnology company. | Biotech | Schlieren, Switzerland | Series C | $11.0M | 2024-09-17 | Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 | 11 to 50 | 2014 | |
| CorFlow Therapeutics | CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. | Biotech | Baar, Switzerland | Series B | $48.5M | 2024-09-10 | $66.1M | Innosuisse, Unorthodox Ventures, Panakes Partners +2 | 11 to 50 | 2016 |
| Vandria | Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders. | Health care | Lausanne, Switzerland | Series A | $10.1M | 2024-08-21 | Innosuisse, Dolby Family Ventures, Eurostars +1 | 1 to 10 | 2021 | |
| Spirecut | Spirecut makes ultrasound-guided instruments that make minimally invasive surgery widely accessible. | Health care | Muttenz, Switzerland | Series A | $800K | 2024-03-26 | $2.2M | Innovate UK, MassChallenge Switzerland, Innosuisse +1 | 1 to 10 | 2020 |
| Hemotune | Hemotune develops a therapeutic blood purification platform for treating health conditions. | Biotech | Schlieren, Switzerland | Series B | $15.6M | 2024-03-25 | Venture Kick, Innosuisse, Gebert Rüf Stiftung | 11 to 50 | 2016 | |
| Galventa | Galventa provides pharmaceutical manufacturing services for a micro-pellet food supplement that relieves sleep inertia symptoms. | Biotech | Saint Gallen, Switzerland | Seed | $1.8M | 2023-12-31 | Venture Kick, Founders Factory, Innosuisse +1 | 11 to 50 | 2018 | |
| PowerAPI | PowerAPI is an open, modular, and intelligent operational software. | Software | Geneva, Switzerland | Seed | $3.5M | 2023-12-22 | $5.5M | Innosuisse, Prediction Capital, 4See Ventures | 11 to 50 | 2018 |
| Scailyte | Scailyte delivers precision medicine through single-cell science. | Artificial intelligence | Basel, Switzerland | Series A | $1.8M | 2023-12-04 | $15.6M | Venture Kick, Verve Ventures, Innosuisse +2 | 11 to 50 | 2017 |
| TissueLabs | TissueLabs is a biotechnology research company that runs a platform for creating organs and tissues in the lab. | Biotech | Bellinzona, Switzerland | Seed | $800K | 2023-10-01 | $1.9M | MassChallenge Switzerland, Innosuisse, Mergus Ventures +2 | 11 to 50 | 2019 |
| Pipra | PIPRA develops an AI-based pre-surgical tool that assesses patients' risk of postoperative cognitive impairment. | Health care | Zürich, Switzerland | Seed | $250K | 2023-01-23 | $3.9M | Plug and Play, Newchip Accelerator, Innosuisse | 11 to 50 | 2019 |
Table 1. Innosuisse portfolio companies: the 19 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 29.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Swisspod | Swisspod develops energy-efficient hyperloop systems for high-speed transportation. | Energy | Monthey, Switzerland | Seed | $13.0M | 2025-11-25 | $25.5M | European Innovation Council, Innosuisse, Seldor Capital +1 | 101 to 250 | 2019 |
| 2 | UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich, Switzerland | Series A | $9.0M | 2026-10-08 | $19.7M | Venture Kick, European Innovation Council, Innosuisse +1 | 11 to 50 | 2018 |
| 3 | Rapidata | Rapidata is a data processing platform that offers human-verified data labeling and processing services at scale. | Hardware | Zürich, Switzerland | Seed | $8.5M | 2026-02-19 | $11.5M | Venture Kick, Acequia Capital (AceCap), Innosuisse +2 | 11 to 50 | 2023 |
| 4 | KEMARO AG | KEMARO AG engineers autonomous robotics. | Artificial intelligence | Eschlikon, Switzerland | Series B | $5.0M | 2026-04-23 | $10.4M | Innosuisse, Spicehaus Partners | 11 to 50 | 2016 |
| 5 | ORamaVR | ORamaVR develops extended reality software that speeds up computational medical applications. | Education | Geneva, Switzerland | Seed | $4.5M | 2026-01-27 | $5.9M | European Commission, Innosuisse, FONGIT +1 | 11 to 50 | 2016 |
Table 2. Innosuisse portfolio companies: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | 10 | 34% | 2 | UniSieve, Rapidata |
| 2 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 4 | 14% | ||
| 3 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | 3 | 10% | 1 | Seprify |
| 4 | Spicehaus Partners | Venture capital firm | Zug, Switzerland | 3 | 10% | 1 | KEMARO AG |
| 5 | SICTIC | Angel group | Zürich, Switzerland | 3 | 10% | ||
| 6 | European Innovation Council | Startup accelerator | Brussels, Belgium | 2 | 7% | 2 | UniSieve, Swisspod |
| 7 | Tenity | Startup accelerator | Zürich, Switzerland | 2 | 7% | ||
| 8 | MassChallenge | Startup accelerator | Boston, United States | 2 | 7% | ||
| 9 | Verve Ventures | Venture capital firm | Zug, Switzerland | 2 | 7% | ||
| 10 | Swisscom Ventures | Venture capital firm | Zürich, Switzerland | 2 | 7% | ||
| 11 | Big Idea Ventures | Startup accelerator | New York, United States | 1 | 3% | 1 | Seprify |
| 12 | University of Cambridge Enterprise | University program | Cambridge, United Kingdom | 1 | 3% | 1 | Seprify |
| 13 | InnoBooster | Startup accelerator | Basel, Switzerland | 1 | 3% | 1 | Seprify |
| 14 | Founderful | Venture capital firm | Zürich, Switzerland | 1 | 3% | 1 | UniSieve |
| 15 | BlueYard Capital | Venture capital firm | Berlin, Germany | 1 | 3% | 1 | Rapidata |
Table 3. Innosuisse portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 17 | 59% | $235.2M |
| Software | 13 | 45% | $73.8M |
| Biotech | 9 | 31% | $198.3M |
| Artificial intelligence | 5 | 17% | $46.4M |
| Hardware | 4 | 14% | $27.9M |
| Energy | 3 | 10% | $45.2M |
| Education | 1 | 3% | $5.9M |
| Fintech | 1 | 3% |
Table 4. Innosuisse portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Innosuisse portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Innosuisse portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 17% | $9.0M |
| April 2026 | 1 | 17% | $5.0M |
| March 2026 | 1 | 17% | $15.6M |
| February 2026 | 1 | 17% | $8.5M |
| January 2026 | 1 | 17% | $4.5M |
| November 2025 | 1 | 17% | $13.0M |
Table 7. Innosuisse portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 17% | $42.6M |
| 2025 | 5 | 17% | $65.7M |
| 2024 | 10 | 34% | $292.7M |
| 2023 | 7 | 24% | $15.8M |
| 2022 | 2 | 7% | $1.3M |
Table 8. Innosuisse portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 3% |
| 2020 to 2022 | 7 | 24% |
| 2015 to 2019 | 18 | 62% |
| 2010 to 2014 | 3 | 10% |
Table 9. Innosuisse portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 8 | 28% |
| 11 to 50 | 18 | 62% |
| 51 to 100 | 2 | 7% |
| 101 to 250 | 1 | 3% |
Table 10. Innosuisse portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Innosuisse is recorded as one of its investors. On 16 November 2026 that is 29 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 19 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 29 rows: 3 have no round amount, 0 no city and 1 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Innosuisse portfolio companies are on the list?
- 29, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 29 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.